MedTrace Logo

Learning and Coping With Early Stage Dementia

NCT03741543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2025-05-14

No results posted yet for this study

Summary

The overall aim of this study is to investigate how home dwelling people with early-stage dementia cope with their disease, explored through their participation in a 12-week health promotion course, through 3 sub-studies; 1) The users' experience in gaining information about dementia and meeting others in the same situation, 2) observation of the group interactions and support processes, and 3) investigate the effect of the 12-week health promotion course for people with early stage dementia on their cognitive function, psychosocial function and health behaviour.

Conditions

  • Dementia
  • Alzheimer Disease
  • Vascular Dementia

Interventions

OTHER

A 12-week health promotion course

The Health Promotion intervention consists of 12 weekly 2-hour sessions with a group of up to six participants and two course facilitators. Teaching methods includes lecture, questions- and answer periods, and interactive hands-on learning. During the class sessions, the facilitators encourages the participants to ask questions and make comments about the lecture at any time. During the first class session, each participant receives a booklet with the course material.

Sponsors & Collaborators

  • The Dam Foundation

    collaborator OTHER

  • The National Association for Public Health, Norway

    collaborator OTHER_GOV

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Ingelin Testad, PhD · Helse Stavanger

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-03
Primary Completion
2019-02-28
Completion
2024-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03741543 on ClinicalTrials.gov